Browse by Audience
Skip to content
Papers of the Week
Lysozyme modulates inflammatory responses to exacerbate the severity of rheumatoid arthritis.
Authors
Xu H, Yin L, Zou L, Zhang E, Cheng Y, Zhang W, Liu Y, Han J, Zhao YAbstract
The mechanisms underlying Rheumatoid Arthritis (RA) remain unclear. Despite having relatively well-defined treatment strategies, current therapeutic approaches only achieve a remission rate of 70 %-80 %, with poor prognosis and no clear diagnostic criteria for early RA. Therefore, there is a need for new therapeutic targets or biomarkers to improve the treatment of RA.